Home-based supervised exercise program beforeHead and neck cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study explores a supervised, home-based adapted physical activity program for patients undergoing head and neck cancer surgery. It targets individuals who have more than two weeks between surgical announcement and procedure and are prescribed adapted physical activity. The approach aims to promote better postoperative functional capacity by integrating physical activity in the preoperative period, potentially improving recovery after surgery. Outcomes will inform feasibility of implementing such a program in routine preoperative care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* surgery requiring the placement of a covering flap)
* Medical prescription of adapted physical activity
* A period of more than 2 weeks between the announcement of surgery and the surgery itself

Exclusion Criteria:

* Absolute contraindications to physical activity
* Pregnant or breastfeeding women
* Patients who, for any reason, are unable to understand the study or comply with the trial requirements (language, psychological, or geographical barriers, etc.)

Where it's running

• Centre Henri Becquerel
  Rouen, France Recruiting

Study contacts

• Principal investigator: Elise Carpentier — Centre Henri Becquerel
• Study coordinator: Elise Carpentier
• Email: elise.carpentier@chb.unicancer.fr
• Phone: +33232082985

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Proton Re-irradiation for Recurrent or Second Primary Head and Neck Cancer

  This study tests proton radiotherapy to see if it can control head and neck cancer that has come back or appeared again in the same area, while trying to limit side effects.

  Recruiting Oslo University Hospital · Bergen and 3 other locations · NCT07922967

• TS-104: a first-in-human, dose-escalation study for advanced solid tumors

  This study tests TS-104, a peptide-drug conjugate, as a single therapy in adults with advanced solid tumors like NSCLC, HNSCC, esophageal, gastric, ovarian, or endometrial cancer to see if it is safe and tolerable and whether it shows any benefit.

  Recruiting at 3 sites Phase 1 TwoStep Therapeutics, Inc. · Maumee, Ohio and 2 other locations · NCT07814248

• BupiZenge vs Lidocaine for mouth pain from oral mucositis in head and neck cancer

  A phase 3 trial tests whether the BupiZenge lozenge provides better pain relief than lidocaine for mouth sores caused by radiation in head and neck cancer patients.

  Recruiting at 9 sites Phase 3 OncoZenge AB · Copenhagen and 10 other locations · NCT07672236

• Proton Re-irradiation for Head and Neck Cancer Recurrence

  This study tests whether proton therapy as a second round of radiation is safe and helpful for adults with head and neck cancer that has come back after prior treatment.

  Recruiting Istituto Clinico Humanitas · Rozzano, Milano · NCT07635641

• Intratumoral EDS01 plus toripalimab for recurrent or metastatic head and neck cancer

  This phase 1 study tests whether directly injecting a gene‑therapy endostatin product (EDS01) into a tumor, together with the PD-1 inhibitor toripalimab, is safe and shows early signs of activity in adults with recurrent or metastatic head and neck cancer after platinum therapy.

  Recruiting Phase 1 West China Hospital · Chengdu, China · NCT07625423

• Specialist nurse-led perioperative nursing care for head and neck cancer surgery

  A multidisciplinary team of specialist nurses tests whether a nurse-led perioperative care plan improves recovery for people having head and neck cancer surgery.

  Recruiting Tianjin Medical University Cancer Institute and Hospital · Tianjin · NCT07622381

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.